Accessibility Menu
Roche Ag Stock Quote

Roche Ag (XSWX: ROG)

$327.70
(-0.6%)
-1.90
Price as of December 29, 2025, 11:30 a.m. ET

KEY DATA POINTS

Current Price
CHF 327.70
Daily Change
(-0.6%) $1.90
Day's Range
CHF 327.60 - CHF 331.00
Previous Close
CHF 327.70
Open
CHF 330.00
Beta
-0.04
Volume
660,192
Average Volume
974,514
Market Cap
$262B
Market Cap / Employee
$329.60M
52wk Range
CHF 231.90 - CHF 331.20
Revenue
N/A
Gross Margin
0.73%
Dividend Yield
2.94%
EPS
CHF 11.75
CAPs Rating
N/A
Industry
Pharmaceuticals

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Roche Ag Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
ROG+29.73%+6.47%+1.26%+2,611%
S&P+15.66%+85.04%+13.1%+1,555%
Advertisement

Roche Ag Company Info

Roche Holding AG is a research healthcare company. It operates through the Pharmaceuticals and Diagnostics segments. The Pharmaceutical division comprises the business segments, such as Roche Pharmaceuticals and Chuga. The Diagnostic division consists of the following four business areas: centralized and point of care solutions, molecular diagnostics, tissue diagnostics and diabetes care. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

News & Analysis

Financial Health

General

No data available

No data available for this period.

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

No data available

No data available for this period.

Liabilities

No data available

No data available for this period.

Ratios

No data available

No data available for this period.

Cash Flow

No data available

No data available for this period.

Valuation

MetricYoY Change

No results found

No podcast episodes available.

No results found

No transcripts available.

Advertisement

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.